Date: May 29, 2018
Hosted by: MS Society of Canada
Presented by: Amy Semaka (Pharm.D.)
‘The Evolving Landscape of MS Treatment’, provides a brief overview of an assortment of subjects from a patient-oriented standpoint. In particular, our presenter discusses the below topics as they pertain to the management of MS.
~Drug development and patient safety
~Biosimilars and their regulation
~Recent drug news and future prospects
~Drug support programs
~The role for atypical and controversial therapies
~Patient advocacy issues
~The role of the pharmacist in MS management
This session was hosted by the Multiple Sclerosis Society of Canada who gratefully acknowledges the support of Biogen who provided an education grant which makes possible the MS Webinar Series.